SCHEMBL21711541

SCHEMBL21711541

COC(=O)C(Br)c1ccc(O)cc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.47
HSD17B10 Q99714 1/20 0.38
MEN1 O00255 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
KMT2A Q03164 1/20 0.38
CA12 O43570 3/20 0.38
CA1 P00915 3/20 0.38
CA2 P00918 3/20 0.38
CA7 P43166 3/20 0.38
CA9 Q16790 3/20 0.38
CA14 Q9ULX7 3/20 0.38
PDK2 Q15119 2/20 0.38
PDK4 Q16654 2/20 0.38
BACE1 P56817 3/20 0.37
NR3C2 P08235 3/20 0.36
ESR2 Q92731 1/20 0.36
MMP2 P08253 1/20 0.36
MMP9 P14780 1/20 0.36
MMP13 P45452 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4026932 0.85 LMNA (0.49) MEN1KMT2ANR3C2
SCHEMBL30369402 0.85 LMNA (0.49) MEN1KMT2ANR3C2
SCHEMBL18103273 0.84 MAPK1 (0.43) MEN1KMT2A
SCHEMBL11295277 0.83 NR3C2 (0.52) NR3C2
SCHEMBL30065589 0.83 NR3C2 (0.52) NR3C2
SCHEMBL27621993 0.82 ESR1 (0.49) ESR1HSD17B10MEN1CYP1A2CYP3A4
SCHEMBL18103271 0.79 PDE2A (0.55) CYP1A2CYP3A4
SCHEMBL14009484 0.78 CASP1 (0.44) KMT2A
SCHEMBL661387 0.78 CASP1 (0.44) KMT2A
SCHEMBL1417549 0.78 CASP1 (0.44) KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10781209-B2 1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins INCYTE CORPORATION (US) 2020-09-22 US disclosed
US-20200048251-A1 1H-PYRROLO[2,3-c]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-c]PYRIDIN-7(6H)-ONES AS INHIBITORS OF BET PROTEINS INCYTE CORPORATION 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10781209-B2 1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins BRD3, BRD1, BRD2 ESR1 2921/4885HSD17B10 4099/4885MEN1 2471/4885
US-20200048251-A1 1H-PYRROLO[2,3-c]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-c]PYRIDIN-7(6H)-ONES AS INHIBITORS OF BET PROTEINS BRD3, BRD1, BRD2 ESR1 2921/4885HSD17B10 4099/4885MEN1 2471/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.